Needham & Company LLC Reiterates “Buy” Rating for Cidara Therapeutics (NASDAQ:CDTX)
Needham & Company LLC restated their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a report published on Thursday,Benzinga reports. They currently have a $35.00 price target on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on CDTX. JMP Securities set a $46.00 price target […]
Needham & Company LLC restated their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a report published on Thursday,Benzinga reports. They currently have a $35.00 price target on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on CDTX. JMP Securities set a $46.00 price target […]
